Edwards Lifesciences Operating Expenses Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 142.34  1.00  0.71%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Operating Expenses of Edwards Lifesciences Corporation with missing and latest data points interpolated. Operating expenses represents the total expenditure on Selling General and Administrative Expense, Research and Development Expense and other operating expense items, it excludes Cost of Revenue.
Operating Expenses  10 Years Trend  
Slightly volatile
 Operating Expenses 

Edwards Lifesciences Operating Expenses Over Time

2016-12-31  1,415,100,000 
2017-12-31  1,415,100,000 
2018-12-31  1,397,842,105 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  910,910,931
Geometric Mean  830,216,044
Coefficient Of Variation  41.26
Mean Deviation  312,873,310
Median  910,300,000
Standard Deviation  375,817,448
Range  1,123,600,000
R Value  0.88
R Squared  0.77
Significance  0.00007298
Slope  84,909,630

Currently Trending

Purchased over 500 shares of
a day ago ago
Traded for 5.25
Purchased over 70 shares of
a day ago ago
Traded for 34.98
Purchased over 30 shares of
a day ago ago
Traded for 92.89